Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Argun Akcakanat

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Cancer Research|October 12, 2011
Targeting PI3K/mTOR signaling in cancerBrooke M Emerling, Argun Akcakanat
Translation (Austin, Tex.)|January 19, 2016
Targeting translation initiation in breast cancerArgun Akcakanat, David S Hong, Funda Meric-Bernstam
Molecular Cancer|September 26, 2009
The rapamycin-regulated gene expression signature determines prognosis for breast cancerArgun Akcakanat, Li Zhang, Spiridon Tsavachidis, et al.
Biochemical and Biophysical Research Communications|August 21, 2007
Rapamycin regulates the phosphorylation of rictorArgun Akcakanat, Gopal Singh, Mien-Chie Hung, et al.
Surgical Oncology Clinics of North America|September 10, 2013
Targeting the PI3-kinase/Akt/mTOR signaling pathwayBurhan Hassan, Argun Akcakanat, Ashley M Holder, et al.
Growth Factors (Chur, Switzerland)|December 17, 2008
Regulation and localization of ribosomal protein S6 kinase 1 isoformsDoyil Kim, Argun Akcakanat, Gopal Singh, et al.
Cancer|April 5, 2008
Comparison of Akt/mTOR signaling in primary breast tumors and matched distant metastasesArgun Akcakanat, Aysegul Sahin, Alexandra N Shaye, et al.
RNA Biology|December 23, 2008
RNA-binding specificity of Y-box protein 1Jinjiang Dong, Argun Akcakanat, David N Stivers, et al.
Nutrition and Cancer|February 5, 2011
The effect of leucine restriction on Akt/mTOR signaling in breast cancer cell lines in vitro and in vivoGopal Singh, Argun Akcakanat, Chandeshwar Sharma, et al.
Endocrine-Related Cancer|March 4, 2008
Antitumor activity of rapamycin and octreotide as single agents or in combination in neuroendocrine tumorsAmy Moreno, Argun Akcakanat, Mark F Munsell, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Cancer Research|October 12, 2011
Targeting PI3K/mTOR signaling in cancerBrooke M Emerling, Argun Akcakanat
Translation (Austin, Tex.)|January 19, 2016
Targeting translation initiation in breast cancerArgun Akcakanat, David S Hong, Funda Meric-Bernstam
Molecular Cancer|September 26, 2009
The rapamycin-regulated gene expression signature determines prognosis for breast cancerArgun Akcakanat, Li Zhang, Spiridon Tsavachidis, et al.
Biochemical and Biophysical Research Communications|August 21, 2007
Rapamycin regulates the phosphorylation of rictorArgun Akcakanat, Gopal Singh, Mien-Chie Hung, et al.
Surgical Oncology Clinics of North America|September 10, 2013
Targeting the PI3-kinase/Akt/mTOR signaling pathwayBurhan Hassan, Argun Akcakanat, Ashley M Holder, et al.
Growth Factors (Chur, Switzerland)|December 17, 2008
Regulation and localization of ribosomal protein S6 kinase 1 isoformsDoyil Kim, Argun Akcakanat, Gopal Singh, et al.
Cancer|April 5, 2008
Comparison of Akt/mTOR signaling in primary breast tumors and matched distant metastasesArgun Akcakanat, Aysegul Sahin, Alexandra N Shaye, et al.
RNA Biology|December 23, 2008
RNA-binding specificity of Y-box protein 1Jinjiang Dong, Argun Akcakanat, David N Stivers, et al.
Nutrition and Cancer|February 5, 2011
The effect of leucine restriction on Akt/mTOR signaling in breast cancer cell lines in vitro and in vivoGopal Singh, Argun Akcakanat, Chandeshwar Sharma, et al.
Endocrine-Related Cancer|March 4, 2008
Antitumor activity of rapamycin and octreotide as single agents or in combination in neuroendocrine tumorsAmy Moreno, Argun Akcakanat, Mark F Munsell, et al.
Pageof 5